NDC 37205-308-64 - LEADER Azo Tabs Urinary Tract Analgesic
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 37205-308
- Requested NDC
- 37205-308-64
- Package NDCs from labels
- 37205-308-64, 37205-308-01
- Manufacturer
- Cardinal Health | Reese Pharmaceutical Co
- Effective date
- 2011-01-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| PHENAZOPYRIDINE HYDROCHLORIDE - Cardinal Health | Reese Pharmaceutical Co | Cardinal Health | Reese Pharmaceutical Co | 2011-01-03 | HUMAN OTC DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 37205-308-01 | 2025-04-11 | C162847 | 48780-1 | 9d75b9d0-d04b-f424-e053-dadaa90a57ce | DRUG FACTS |
| 37205-308-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-d04b-f424-e053-dadaa90a57ce | DRUG FACTS |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 37205-308-64 | EA - Each | 37205-308 | 8da71656-c82c-4555-96f8-053318136647 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| AZO | URINARY PAIN RELIEF | i-Health, Inc. | 3d0298b7-eaec-488b-9cab-19af4614ff53 | 2026-01-05 | Warnings | 0EWG668W17 |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE | Northwind Health Company, LLC | f2f3e29f-9553-f7c3-e053-2995a90aff36 | 2026-01-01 | Adverse reactions | 0EWG668W17 |
| B03 Sinus Relief | ALLIUM CEPA, CALCAREA IODATA, CALCAREA SULPHURICA, ECHINACEA ANGUSTIFOLIA, ECHINACEA PURPUREA, EUPHORBIUM OFFICINARUM, HEPAR SULPHURIS CALCAREUM, HISTAMINUM HYDROCHLORICUM, HYDRASTIS CANADENSIS, KALI BICHROMICUM, KALI MURIATICUM, KALI SULPHURICUM, LAC DEFLORATUM, LUFFA OPERCULATA, MERCURIUS SULPHURATUS RUBER, PHOSPHORUS, PULSATILLA VULGARIS, SACCHARUM LACTIS, THUJA OCCIDENTALIS | Apex Energetics Inc. | bad83f77-e9ae-7118-e053-2a95a90aa737 | 2025-12-31 | Warnings | J2B2A4N98G |
| Maximum Strength Urinary Pain Relief | PHENAZOPYRIDINE HYDROCHLORIDE | TARGET CORPORATION | e6e27e7f-d04c-5a49-e053-2a95a90a776a | 2025-12-30 | Warnings | 0EWG668W17 |
| Vexia Maximum Strength Urinary Pain Relief | PHENAZOPYRIDINE HYDROCHLORIDE | Reese Pharmaceutical Co | 5fbc47d2-cecd-4187-9bcc-51b1d0b7695d | 2025-12-29 | Warnings | 0EWG668W17 |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE | Northwind Health Company, LLC | f29f2ed6-6fd1-fd65-e053-2a95a90aedc4 | 2025-12-26 | Adverse reactions | 0EWG668W17 |
| PHENAZOPYRIDINE HYDROCHLORIDE | PHENAZOPYRIDINE HYDROCHLORIDE | Chartwell RX, LLC | 9ed3cf8c-e1c1-4290-b094-25ac6f7a9a56 | 2025-12-11 | Adverse reactions | 0EWG668W17 |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE HYDROCHLORIDE | A-S Medication Solutions | d514fd31-feeb-4371-9b28-eec9834a7003 | 2025-12-10 | Warnings, Adverse reactions | 0EWG668W17 |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE HYDROCHLORIDE | A-S Medication Solutions | cd78a132-037c-412a-9c56-e38367e05c92 | 2025-12-10 | Warnings, Adverse reactions | 0EWG668W17 |
| Quality Choice Urinary Pain Relief | PHENAZOPYRIDINE HYDROCHLORIDE | Chain Drug Marketing Association | 45e0cc2f-4a25-40ef-86ed-d1212815d751 | 2025-12-02 | Warnings | 0EWG668W17 |
| Quality Choice Maximum Strength Urinary Pain Relief | PHENAZOPYRIDINE HYDROCHLORIDE | Chain Drug Marketing Association | 3cee4fea-f1ef-4020-9b55-02b794b12820 | 2025-12-02 | Warnings | 0EWG668W17 |
| AZO Urinary Pain Relief Maximum Strength | PHENAZOPYRIDINE HYDROCHLORIDE | i-Health, Inc. | b4874fe2-d98b-4b5c-baad-d75070947842 | 2025-11-17 | Warnings | 0EWG668W17 |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE | VERITYRX, LLC | 427b6ffb-3ff1-932f-e063-6394a90ae8b9 | 2025-10-31 | Adverse reactions | 0EWG668W17 |
| Uqora Maximum UTI Pain Relief | PHENAZOPYRIDINE HYDROCHLORIDE | Bonafide Health, LLC dba Uqora | 426317e7-a925-116a-e063-6294a90a52dc | 2025-10-27 | Warnings | 0EWG668W17 |
| Uristat Ultra | PHENAZOPYRIDINE HYDROCHLORIDE | Medtech Products Inc. | c705185f-4908-451e-993b-b0b8a73f0392 | 2025-10-23 | Warnings | 0EWG668W17 |
| Monistat Maintain | PHENAZOPYRIDINE HYDROCHLORIDE | Insight Pharmaceuticals LLC | d1e563fc-5a91-4867-8177-93102bd24fe4 | 2025-10-23 | Warnings | 0EWG668W17 |
| Sugar Cravings | CINNAMIC ACID, PHLORIDZINUM, ARGENTUM NITRICUM, ADENOSINUM TRIPHOSPHORICUM DINATRUM, BEET SUGAR, DEXTROSE, D-RIBOSE, FRUCTOSE, LYCOPODIUM CLAVATUM, MAPLE SUGAR, SACCHARUM LACTIS, SACCHARUM OFFICINALE, SARCOLACTICUM ACIDUM, MALVIN, ADRENOCORTICOTROPHIN, DYSENTERY BACILLUS, MORGAN GAERTNER | Dr. Donna Restivo DC | 401873ba-ae1b-4506-a2e8-c6c0e5ff27f5 | 2025-10-21 | Warnings | J2B2A4N98G |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE | Bryant Ranch Prepack | 6ac0f3ce-0cc2-403c-946d-13b285ae98aa | 2025-09-19 | Adverse reactions | 0EWG668W17 |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE | A-S Medication Solutions | d8155f91-d650-4021-91ee-f3b6c1055a36 | 2025-09-05 | Adverse reactions | 0EWG668W17 |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE | A-S Medication Solutions | 900222e8-fc92-4d73-b3d5-1636e717bd65 | 2025-09-05 | Adverse reactions | 0EWG668W17 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.